Distinct pattern of PCR-SSCP analysis of p53 mutations in human astrocytomas

Cancer Letters

Volumn 141, Issue 1-2, 1999, Pages 195-201

  Thangnipon, Wipawan ^a   Mizoguchi, Masahiro ^b   Kukita, Yoji ^b   Inazuka, Masakazu ^b   Iwaki, Toru ^b   Fukui, Masashi ^b   Hayashi, Kenshi ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Astrocytoma; Klenow fragment; Low pH; p53 gene; PCR SSCP

Indexed keywords

PROTEIN P53;

ARTICLE; ASTROCYTOMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC MUTATION;

ASTROCYTOMA; BRAIN NEOPLASMS; DNA MUTATIONAL ANALYSIS; EXONS; HUMANS; LOSS OF HETEROZYGOSITY; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033045956     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00101-9     Document Type: Article

References (28)

1. Silverberg E., Boring C.C., Squires B.A. Cancer statistics. CA Cancer J. Clin. 40:1990;9-26.
2. Kleihues P., Burger P.C., Scheithauer B.W. The new WHO classification of brain tumours. Brain Pathol. 3:1993;255-268.
3. von Deimling A., Louis D.N., Schramm J., Wiestler O.D. Astrocytic gliomas: characterization on a molecular genetic basis. Recent Results Cancer Res. 135:1994;33-42.
4. Bishop J.M. Molecular themes in oncogenesis. Cell. 64:1991;235-248.
5. Marshall C.J. Tumor suppressor genes. Cell. 64:1991;313-326.
6. Hollstein M., Sidransky D., Vogelstein B., Harris C.C. p53 Mutations in human cancers. Science. 253:1991;49-53.
7. Mashiyama S., Murakami Y., Yoshimoto T., Sekiya T., Hayashi K. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene. 6:1991;1313-1318.
8. Sidransky D., Mikkelsen T., Schwechheimer K., Rosenblum M.L., Cavanee W., Vogelstein B. Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature. 355:1992;846-847.
9. von Deimling A., Eibl R.H., Ohgaki H., Louis D.N., von Ammon K., Petersen I., Kleihues P., Chung R.Y., Wiestler O.D., Seizinger B.R. p53 mutations are associated with 17p allelic loss in grade II and III astrocytoma. Cancer Res. 52:1992;2987-2990.
10. Chung R., Whaley J., Kley N., Anderson K., Louis D., Menon A., Hettich C., Freiman R., Hedley-Whyte E.T., Martuza R., Jenkins R., Yandell D., Seizinger B.R. TP53 gene mutations and 17p deletions in human astrocytomas. Genes Chromosomes Cancer. 3:1991;323-331.
11. Frankel R.H., Bayona W., Koslow M., Newcomb E.W. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency. Cancer Res. 52:1992;1427-1433.
12. Fults D., Brockmeyer D., Tullous M.W., Pedone C.A., Cawthon R.M. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res. 52:1992;674-679.
13. Louis D.N., von Deimling A., Chung R.Y., Rubio M.P., Whaley J.M., Eibl R.H., Ohgaki H., Wiestler O.D., Thor A.D., Seizinger B.R. Comparative study of p53 gene and protein alterations in human astrocytic tumors. J. Neuropathol. Exp. Neurol. 52:1993;31-38.
14. Ohgaki H., Eibl R.H., Schwab M., Reichel M.B., Mariani L., Gehring M., Peterson I., Holl T., Wiestler O.D., Kleihues P. Mutations of the p53 tumor suppressor gene in neoplasmas of the human nervous system. Mol. Carcinogenesis. 8:1993;74-80.
15. Lang F.F., Miller D.C., Koslow M., Newcomb E.W. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. J. Neurosurg. 81:1994;427-436.
16. Newcomb E.W., Madonia W.J., Pisharody S., Lang F.F., Koslow M., Miller D.C. A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme. Brain Pathol. 3:1993;229-235.
17. Kukita Y., Tahira T., Sommer S.S., Hayashi K. Screening analysis of long DNA fragments in low pH gel. Hum. Mutat. 10:1997;400-407.
18. Blin N., Stafford D.M. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res. 3:1976;2303-2308.
19. Buchman V.L., Chumakov P.M., Ninkina N.N., Samarina O.P., Georgiev G.P. A variation in the structure of the protein-coding region of the human p53 gene. Gene. 70:1988;245-252.
20. Mashiyama S., Sekiya T., Hayashi K. Screening of multiple DNA samples for detection of sequence changes. Technique. 2:1990;304-306.
21. Gyapay G., Morissette J., Vignal A., Dib C., Fizames C., Millasseau P., Marc S., Bernardi G., Lathrop M., Weissenbach J. The 1993-1994 Genethon human genetic linkage map. Nat. Genet. 7:1994;246-339.
22. Hayashi K. PCR-SSCP single-strand conformation polymorphism analysis of PCR products. Landegren U. Laboratory Protocols for Mutation Detection. 1996;14-22 Oxford University Press, Oxford.
23. de Fromentel C.C., Soussi T. TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosomes Cancer. 4:1992;1-15.
24. Hollstein M., Shomer B., Greenblatt M., Soussi T., Hovig E., Montesano R., Harris C.C. Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res. 24:1996;141-146.
25. Koga H., Zhang S., Kumanishi T., Washiyams K., Ichikawa T., Tanaka R., Mukawa J. Analysis of p53 gene mutations in low-and high-grade astrocytomas by polymerase chain reaction-assisted single-strand conformation polymorphism and immunohistochemistry. Acta Neuropathol. 87:1994;225-232.
26. Kyritsis A.P., Xu R., Bondy M.L., Levin V.A., Brunerdy M.L., Levin V.A., Bruner J.M. Correlation of p53 immunoreactivity and sequencing in patients with glioma. Mol. Carcinogen. 15:1996;1-4.
27. Chen P., Lavaronne A., Fick J., Edwards M., Prados M., Israel M.A. Constitutional p53 mutations associated with brain tumors in young adults. Cancer Genet. Cytogenet. 82:1995;106-115.
28. Orellana C., Hernandez-Marti M., Martinez F., Castel V., Millan J.M., Alvarez-Garijo J.A., Prieto F., Badia L. Pediatric brain tumors: loss of heterozygosity at 17p and TP53 gene mutations. Cancer Genet. Cytogenet. 102:1998;93-99.